Your browser doesn't support javascript.
loading
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma.
Stamato, Maria Angelica; Juli, Giada; Romeo, Enrica; Ronchetti, Domenica; Arbitrio, Mariamena; Caracciolo, Daniele; Neri, Antonino; Tagliaferri, Pierosandro; Tassone, Pierfrancesco; Amodio, Nicola.
Afiliación
  • Stamato MA; Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • Juli G; Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • Romeo E; Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • Ronchetti D; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Arbitrio M; Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Caracciolo D; ISN-CNR, Roccelletta di Borgia, Catanzaro, Italy.
  • Neri A; Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • Tagliaferri P; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Tassone P; Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Amodio N; Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.
Oncotarget ; 8(63): 106527-106537, 2017 Dec 05.
Article en En | MEDLINE | ID: mdl-29290968

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Italia